PEAK6 Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$170K	Buy	+1,800	New	+$158K	﹤0.01%	3441
2018 Q1	–	Sell	-64,200	Closed	-$5.72M	–	4340
2017 Q4	$5.72M	Buy	64,200 +12,700	+25%	+$1.1M	0.03%	744
2017 Q3	$4.79M	Sell	51,500 -59,400	-54%	-$5.25M	0.02%	775
2017 Q2	$10.1M	Buy	110,900 +91,000	+457%	+$8.28M	0.06%	373
2017 Q1	$1.75M	Sell	19,900 -7,300	-27%	-$649K	0.01%	1251
2016 Q4	$2.25M	Sell	27,200 -18,100	-40%	-$1.56M	0.02%	1217
2016 Q3	$4.19M	Sell	45,300 -14,100	-24%	-$1.33M	0.03%	795
2016 Q2	$4.62M	Sell	59,400 -78,200	-57%	-$6.65M	0.04%	713
2016 Q1	$11.3M	Buy	137,600 +120,500	+705%	+$9.8M	0.09%	277
2015 Q4	$1.79M	Buy	17,100 +6,800	+66%	+$710K	0.01%	1437
2015 Q3	$1.08M	Sell	10,300 -12,900	-56%	-$1.72M	0.01%	2119
2015 Q2	$3.17M	Sell	23,200 -41,300	-64%	-$5.12M	0.02%	1140
2015 Q1	$8.04M	Sell	64,500 -21,200	-25%	-$2.25M	0.06%	419
2014 Q4	$7.75M	Buy	85,700 +74,100	+639%	+$6.16M	0.06%	418
2014 Q3	$837K	Sell	11,600 -8,300	-42%	-$545K	0.01%	1979
2014 Q2	$1.24M	Buy	19,900 +16,900	+563%	+$1.02M	0.01%	1459
2014 Q1	$205K	Sell	3,000 -62,100	-95%	-$4.58M	﹤0.01%	3409
2013 Q4	$4.58M	Sell	65,100 -147,300	-69%	-$10M	0.03%	790
2013 Q3	$7.67M	Buy	212,400 +167,400	+372%	+$11.1M	0.05%	461
2013 Q2	$2.51K	Buy	+45,000	New	+$2.8M	0.01%	1315